médecine/sciences (m/s) journal today
Inserm, which owns the title, is continuing the mission entrusted to médecine/sciences at its inception, and clearly summarised in its title: a continuous flow between “sciences” as knowledge production, and “medicine,” as a source of knowledge in itself; m/s is an academic journal for the communication of academic knowledge and learning, unlike any other and probably with no equivalent in Europe. In its political and international francophone dimension, it occupies a position at the heart of modern science and medicine, with an increasingly marked social awareness.
The journal, in hard copy and electronic versions, has always been produced in France.
médecine/sciences is open access 1 year after publication. For the first year of publication, access to articles is restricted to subscribers, mainly scientists via their research organisations (Inserm, CNRS [French National Centre for Scientific Research], EFS [French National Blood Service], etc.) or their universities (Laval, Sherbrooke, Liège, etc.).
A database of the m/s archives, produced by Inserm on the iPubli website, offers open access to the journal’s archives, other than the current year, for which issues can be accessed on the publisher’s website.
Steady growth has been observed in the number of visits to the website and the number of article downloads during the last three years. In 2014, visits to the website were as follows: 11,700 unique users per month (45% of visits from France, followed by the United States and China); and 120,000 article downloads in PDF format per year. Analysis of connection sources suggests that half of visits are from France and half from the rest of the world.
A brief history of a resounding success
In the very early 1980s, programmes of action launched by the French and Quebec governments led to the creation of médecine/sciences (m/s), an international French-language journal reviewing biomedical research.
Professor Jean Hamburger, a pioneer and dedicated supporter of the project, surrounded by a team of young researchers and clinician researchers (Xavier Bertagna, Laurent Degos, Serge Erlinger, Jean-Pierre Grünfeld, Axel Kahn, Claude Matuchansky), would specify its content.
Four sections: an editorial, review articles making up the body of the journal, science news, and original research notes.
Research and higher education institutions would also join the effort for the “Promotion of French, a language of science, and dissemination of scientific and technical culture,” one of the 7 motivational programmes of the Framework Act for Technological Research and Development in France.
An international memorandum of understanding between the French and Quebec governments was signed in May 1984.
In March 1985, m/s was launched in France by Hubert Curien, French Minister of Research and Technology, and in Quebec by Bernard Landry, Quebec Minister of International Relations.
The memorandum would be regularly renewed until February 2006. At this time, the m/s title became the property of Inserm.
In addition, m/s publishes at least one Special Issue per year, and one or more Thematic Series consisting of articles spanning several issues, comprehensive states of the art, each covering a single rapidly expanding medical subject.
The médecine/sciences readership
Researchers, hospital academics, physicians, educators, and especially students, doctoral students and post-doctoral fellows.
The French and Quebec founding members of médecine/sciences
For France: Ministry of Foreign Affairs, Ministry of Research and Technology; National Ministry of Education (DBMIST); Inserm; CNRS; and Haut Comité de la Langue Française (High Commission for the French Language), subsequently the Délégation à la Langue Française (Delegation for the French language).
For Quebec: Ministry of International Relations; Conseil de la Langue Française (French Language Council); Quebec Health Research Fund (FRSQ); and Ministry of Higher Education, Science and Technology.
 Under a public service delegation contract (DSP) between Inserm and a private publisher, successively Flammarion Médecine, John Libbey, Masson, EDK since 2002 and EDK/EDP Sciences since 2012.
ZIKAlliance, a multidisciplinary and multinational research consortium coordinated by Inserm, has received €12 million from the European Union’s Horizon 2020 research and innovation programme to conduct a large-scale 3-year research project on Zika virus (ZIKV) infection in Latin America and the Caribbean. ...
The European Patents Office (EPO) has just published its annual rankings: For the first time, Inserm has taken the top ranking for applicants in the pharmaceutical sector ahead of the big industrial companies and can confirm at the same time its top ...